Neurologic Disorders in the Older Patient

Article Type
Changed
Display Headline
Neurologic Disorders in the Older Patient
A primer on diagnosis and management for primary care

 

Supplement Editors:
Robert M. Palmer, MD, MPH, and Richard J. Lederman, MD, PhD

Contents

Preface: Internists and the older patient with neurologic illness
Robert M. Palmer, MD, MPH, and Richard J. Lederman, MD, PhD

The art of managing dementia in the elderly
Adam Rosenblatt, MD

Preventing ischemic stroke in the older adult
Geoffrey S.F. Ling, MD, PhD, and Shari M. Ling, MD

Seizures in the elderly: Nuances in presentation and treatment
Elizabeth Waterhouse, MD, and Alan Towne, MD

Movement disorders in the older patient: Differential diagnosis and general management
Mark S. Baron, MD

Depression in older patients with neurologic illness: Causes, recognition, management
Alan Carson, MBChB, MPhil, MD, and Richard Margolin, MD

 

Article PDF
Issue
Cleveland Clinic Journal of Medicine - 72(10)
Publications
Topics
Page Number
S1-S64
Sections
Article PDF
Article PDF
A primer on diagnosis and management for primary care
A primer on diagnosis and management for primary care

 

Supplement Editors:
Robert M. Palmer, MD, MPH, and Richard J. Lederman, MD, PhD

Contents

Preface: Internists and the older patient with neurologic illness
Robert M. Palmer, MD, MPH, and Richard J. Lederman, MD, PhD

The art of managing dementia in the elderly
Adam Rosenblatt, MD

Preventing ischemic stroke in the older adult
Geoffrey S.F. Ling, MD, PhD, and Shari M. Ling, MD

Seizures in the elderly: Nuances in presentation and treatment
Elizabeth Waterhouse, MD, and Alan Towne, MD

Movement disorders in the older patient: Differential diagnosis and general management
Mark S. Baron, MD

Depression in older patients with neurologic illness: Causes, recognition, management
Alan Carson, MBChB, MPhil, MD, and Richard Margolin, MD

 

 

Supplement Editors:
Robert M. Palmer, MD, MPH, and Richard J. Lederman, MD, PhD

Contents

Preface: Internists and the older patient with neurologic illness
Robert M. Palmer, MD, MPH, and Richard J. Lederman, MD, PhD

The art of managing dementia in the elderly
Adam Rosenblatt, MD

Preventing ischemic stroke in the older adult
Geoffrey S.F. Ling, MD, PhD, and Shari M. Ling, MD

Seizures in the elderly: Nuances in presentation and treatment
Elizabeth Waterhouse, MD, and Alan Towne, MD

Movement disorders in the older patient: Differential diagnosis and general management
Mark S. Baron, MD

Depression in older patients with neurologic illness: Causes, recognition, management
Alan Carson, MBChB, MPhil, MD, and Richard Margolin, MD

 

Issue
Cleveland Clinic Journal of Medicine - 72(10)
Issue
Cleveland Clinic Journal of Medicine - 72(10)
Page Number
S1-S64
Page Number
S1-S64
Publications
Publications
Topics
Article Type
Display Headline
Neurologic Disorders in the Older Patient
Display Headline
Neurologic Disorders in the Older Patient
Sections
Citation Override
Cleveland Clinic Journal of Medicine 2005 October;72(10 suppl 3):S1-S64
Disallow All Ads
Content Gating
No Gating (article Unlocked/Free)
Alternative CME
Disqus Comments
Default
Gate On Date
Un-Gate On Date
Use ProPublica
CFC Schedule Remove Status
Hide sidebar & use full width
render the right sidebar.
Article PDF Media

Preface: Internists and the older patient with neurologic illness

Article Type
Changed
Display Headline
Preface: Internists and the older patient with neurologic illness
Article PDF
Author and Disclosure Information

Robert M. Palmer, MD, MPH
Section Head, Geriatrics, Department of General Internal Medicine, The Cleveland Clinic

Richard J. Lederman, MD, PhD
Department of Neurology, The Cleveland Clinic

Dr. Palmer reported that he serves on the speakers' bureau of the Pfizer corporation.

Dr. Lederman reported that he has no financial interest or affiliations that pose a potential conflict of interest with his role as co-editor of this supplement.

 

Publications
Page Number
S2
Author and Disclosure Information

Robert M. Palmer, MD, MPH
Section Head, Geriatrics, Department of General Internal Medicine, The Cleveland Clinic

Richard J. Lederman, MD, PhD
Department of Neurology, The Cleveland Clinic

Dr. Palmer reported that he serves on the speakers' bureau of the Pfizer corporation.

Dr. Lederman reported that he has no financial interest or affiliations that pose a potential conflict of interest with his role as co-editor of this supplement.

 

Author and Disclosure Information

Robert M. Palmer, MD, MPH
Section Head, Geriatrics, Department of General Internal Medicine, The Cleveland Clinic

Richard J. Lederman, MD, PhD
Department of Neurology, The Cleveland Clinic

Dr. Palmer reported that he serves on the speakers' bureau of the Pfizer corporation.

Dr. Lederman reported that he has no financial interest or affiliations that pose a potential conflict of interest with his role as co-editor of this supplement.

 

Article PDF
Article PDF
Related Articles
Page Number
S2
Page Number
S2
Publications
Publications
Article Type
Display Headline
Preface: Internists and the older patient with neurologic illness
Display Headline
Preface: Internists and the older patient with neurologic illness
Citation Override
Cleveland Clinic Journal of Medicine 2005 October;72(suppl 3):S2
Disallow All Ads
Content Gating
No Gating (article Unlocked/Free)
Alternative CME
Disqus Comments
Default
Gate On Date
Un-Gate On Date
Use ProPublica
CFC Schedule Remove Status
Article PDF Media

The end of the diet debates? All fats and carbs are not created equal

Article Type
Changed
Display Headline
The end of the diet debates? All fats and carbs are not created equal
Article PDF
Author and Disclosure Information

Arthur S. Agatston, MD
Agatston Research Institute, Miami Beach, FL; Dr. Agatston, a preventive cardiologist, is author of the South Beach Diet and developed the Agatston calcium score

Address: Arthur S. Agatston, MD, FACC, Agatston Research Institute, 4302 Alton Road, Suite 710, Miami Beach, FL 33140

Medical Grand Rounds articles are based on edited transcripts from Heart Center Grand Rounds presentations at The Cleveland Clinic. They are approved by the author but are not peer-reviewed.

Issue
Cleveland Clinic Journal of Medicine - 72(10)
Publications
Topics
Page Number
946-950
Sections
Author and Disclosure Information

Arthur S. Agatston, MD
Agatston Research Institute, Miami Beach, FL; Dr. Agatston, a preventive cardiologist, is author of the South Beach Diet and developed the Agatston calcium score

Address: Arthur S. Agatston, MD, FACC, Agatston Research Institute, 4302 Alton Road, Suite 710, Miami Beach, FL 33140

Medical Grand Rounds articles are based on edited transcripts from Heart Center Grand Rounds presentations at The Cleveland Clinic. They are approved by the author but are not peer-reviewed.

Author and Disclosure Information

Arthur S. Agatston, MD
Agatston Research Institute, Miami Beach, FL; Dr. Agatston, a preventive cardiologist, is author of the South Beach Diet and developed the Agatston calcium score

Address: Arthur S. Agatston, MD, FACC, Agatston Research Institute, 4302 Alton Road, Suite 710, Miami Beach, FL 33140

Medical Grand Rounds articles are based on edited transcripts from Heart Center Grand Rounds presentations at The Cleveland Clinic. They are approved by the author but are not peer-reviewed.

Article PDF
Article PDF
Related Articles
Issue
Cleveland Clinic Journal of Medicine - 72(10)
Issue
Cleveland Clinic Journal of Medicine - 72(10)
Page Number
946-950
Page Number
946-950
Publications
Publications
Topics
Article Type
Display Headline
The end of the diet debates? All fats and carbs are not created equal
Display Headline
The end of the diet debates? All fats and carbs are not created equal
Sections
Disallow All Ads
Alternative CME
Use ProPublica
Article PDF Media

Sleep apnea is linked to heart failure, but does treatment improve outcome?

Article Type
Changed
Display Headline
Sleep apnea is linked to heart failure, but does treatment improve outcome?
Article PDF
Author and Disclosure Information

Laura Wexler, MD
Associate Dean, Student Affairs and Admissions, Professor of Medicine/Cardiology, University of Cincinnati College of Medicine, Cincinnati, OH

Shahrokh Javaheri, MD
Emeritus Professor of Medicine, University of Cincinnati College of Medicine; Medical Director, SleepCare Diagnostics, Cincinnati, OH

Address: Shahrokh Javaheri, MD, SleepCare Diagnostics, 4780 Socialville-Foster Road, Mason, OH 45050; e-mail [email protected]

Dr. Javaheri has indicated that he is on the speaker’s bureaus of companies that make devices used to treat sleep apnea.

Issue
Cleveland Clinic Journal of Medicine - 72(10)
Publications
Topics
Page Number
929-936
Sections
Author and Disclosure Information

Laura Wexler, MD
Associate Dean, Student Affairs and Admissions, Professor of Medicine/Cardiology, University of Cincinnati College of Medicine, Cincinnati, OH

Shahrokh Javaheri, MD
Emeritus Professor of Medicine, University of Cincinnati College of Medicine; Medical Director, SleepCare Diagnostics, Cincinnati, OH

Address: Shahrokh Javaheri, MD, SleepCare Diagnostics, 4780 Socialville-Foster Road, Mason, OH 45050; e-mail [email protected]

Dr. Javaheri has indicated that he is on the speaker’s bureaus of companies that make devices used to treat sleep apnea.

Author and Disclosure Information

Laura Wexler, MD
Associate Dean, Student Affairs and Admissions, Professor of Medicine/Cardiology, University of Cincinnati College of Medicine, Cincinnati, OH

Shahrokh Javaheri, MD
Emeritus Professor of Medicine, University of Cincinnati College of Medicine; Medical Director, SleepCare Diagnostics, Cincinnati, OH

Address: Shahrokh Javaheri, MD, SleepCare Diagnostics, 4780 Socialville-Foster Road, Mason, OH 45050; e-mail [email protected]

Dr. Javaheri has indicated that he is on the speaker’s bureaus of companies that make devices used to treat sleep apnea.

Article PDF
Article PDF
Issue
Cleveland Clinic Journal of Medicine - 72(10)
Issue
Cleveland Clinic Journal of Medicine - 72(10)
Page Number
929-936
Page Number
929-936
Publications
Publications
Topics
Article Type
Display Headline
Sleep apnea is linked to heart failure, but does treatment improve outcome?
Display Headline
Sleep apnea is linked to heart failure, but does treatment improve outcome?
Sections
PURLs Copyright

Disallow All Ads
Alternative CME
Use ProPublica
Article PDF Media

Respiratory tract infections: Another reason not to smoke

Article Type
Changed
Display Headline
Respiratory tract infections: Another reason not to smoke
Article PDF
Author and Disclosure Information

Susan Murin, MD, MSc
Division of Pulmonary and Critical Care Medicine, University of California at Davis School of Medicine; Veterans Administration Northern California Health Care System, Sacramento

Kathryn Smith Bilello, MD
Department of Medicine, University of California, San Francisco at Fresno and University Medical Center, Fresno

Address: Susan Murin, MD, MSc, Division of Pulmonary and Critical Care Medicine, University of California, Davis Medical Center, 4150 V Street, Suite 3400, Sacramento, CA 95817

Issue
Cleveland Clinic Journal of Medicine - 72(10)
Publications
Topics
Page Number
916-920
Sections
Author and Disclosure Information

Susan Murin, MD, MSc
Division of Pulmonary and Critical Care Medicine, University of California at Davis School of Medicine; Veterans Administration Northern California Health Care System, Sacramento

Kathryn Smith Bilello, MD
Department of Medicine, University of California, San Francisco at Fresno and University Medical Center, Fresno

Address: Susan Murin, MD, MSc, Division of Pulmonary and Critical Care Medicine, University of California, Davis Medical Center, 4150 V Street, Suite 3400, Sacramento, CA 95817

Author and Disclosure Information

Susan Murin, MD, MSc
Division of Pulmonary and Critical Care Medicine, University of California at Davis School of Medicine; Veterans Administration Northern California Health Care System, Sacramento

Kathryn Smith Bilello, MD
Department of Medicine, University of California, San Francisco at Fresno and University Medical Center, Fresno

Address: Susan Murin, MD, MSc, Division of Pulmonary and Critical Care Medicine, University of California, Davis Medical Center, 4150 V Street, Suite 3400, Sacramento, CA 95817

Article PDF
Article PDF
Issue
Cleveland Clinic Journal of Medicine - 72(10)
Issue
Cleveland Clinic Journal of Medicine - 72(10)
Page Number
916-920
Page Number
916-920
Publications
Publications
Topics
Article Type
Display Headline
Respiratory tract infections: Another reason not to smoke
Display Headline
Respiratory tract infections: Another reason not to smoke
Sections
PURLs Copyright

Disallow All Ads
Alternative CME
Use ProPublica
Article PDF Media

Eating disorders: Recognize early to prevent complications

Article Type
Changed
Display Headline
Eating disorders: Recognize early to prevent complications
Article PDF
Author and Disclosure Information

Elizabeth H.W. Ricanati, MD
Department of General Internal Medicine, The Gault Women’s Health and Breast Pavilion, The Cleveland Clinic Foundation

Ellen S. Rome, MD, MPH
Head, Section of Adolescent Medicine, Department of Pediatrics, The Children’s Hospital at The Cleveland Clinic Foundation

Address: Elizabeth H.W. Ricanati, MD, The Gault Women’s Health and Breast Pavillion, A10, The Cleveland Clinic Foundation, 9500 Euclid Avenue, Cleveland, OH 44195; e-mail [email protected]

Dr. Rome has indicated that she is on the speakers’ bureaus of the Wyeth-Ayerst and Pfizer corporations.

Issue
Cleveland Clinic Journal of Medicine - 72(10)
Publications
Topics
Page Number
895-896, 898-900, 902, 904-906
Sections
Author and Disclosure Information

Elizabeth H.W. Ricanati, MD
Department of General Internal Medicine, The Gault Women’s Health and Breast Pavilion, The Cleveland Clinic Foundation

Ellen S. Rome, MD, MPH
Head, Section of Adolescent Medicine, Department of Pediatrics, The Children’s Hospital at The Cleveland Clinic Foundation

Address: Elizabeth H.W. Ricanati, MD, The Gault Women’s Health and Breast Pavillion, A10, The Cleveland Clinic Foundation, 9500 Euclid Avenue, Cleveland, OH 44195; e-mail [email protected]

Dr. Rome has indicated that she is on the speakers’ bureaus of the Wyeth-Ayerst and Pfizer corporations.

Author and Disclosure Information

Elizabeth H.W. Ricanati, MD
Department of General Internal Medicine, The Gault Women’s Health and Breast Pavilion, The Cleveland Clinic Foundation

Ellen S. Rome, MD, MPH
Head, Section of Adolescent Medicine, Department of Pediatrics, The Children’s Hospital at The Cleveland Clinic Foundation

Address: Elizabeth H.W. Ricanati, MD, The Gault Women’s Health and Breast Pavillion, A10, The Cleveland Clinic Foundation, 9500 Euclid Avenue, Cleveland, OH 44195; e-mail [email protected]

Dr. Rome has indicated that she is on the speakers’ bureaus of the Wyeth-Ayerst and Pfizer corporations.

Article PDF
Article PDF
Issue
Cleveland Clinic Journal of Medicine - 72(10)
Issue
Cleveland Clinic Journal of Medicine - 72(10)
Page Number
895-896, 898-900, 902, 904-906
Page Number
895-896, 898-900, 902, 904-906
Publications
Publications
Topics
Article Type
Display Headline
Eating disorders: Recognize early to prevent complications
Display Headline
Eating disorders: Recognize early to prevent complications
Sections
Disallow All Ads
Alternative CME
Use ProPublica
Article PDF Media

Hypersensitivity to Once Daily Abacavir

Article Type
Changed
Display Headline
Hypersensitivity to Once Daily Abacavir

Article PDF
Author and Disclosure Information

Issue
Federal Practitioner - 22(10)
Publications
Topics
Page Number
54
Legacy Keywords
HIV, abacavir, hypersensitivity, once daily, regimen, twice, risk, advantage, reactions, severeHIV, abacavir, hypersensitivity, once daily, regimen, twice, risk, advantage, reactions, severe
Sections
Author and Disclosure Information

Author and Disclosure Information

Article PDF
Article PDF

Issue
Federal Practitioner - 22(10)
Issue
Federal Practitioner - 22(10)
Page Number
54
Page Number
54
Publications
Publications
Topics
Article Type
Display Headline
Hypersensitivity to Once Daily Abacavir
Display Headline
Hypersensitivity to Once Daily Abacavir
Legacy Keywords
HIV, abacavir, hypersensitivity, once daily, regimen, twice, risk, advantage, reactions, severeHIV, abacavir, hypersensitivity, once daily, regimen, twice, risk, advantage, reactions, severe
Legacy Keywords
HIV, abacavir, hypersensitivity, once daily, regimen, twice, risk, advantage, reactions, severeHIV, abacavir, hypersensitivity, once daily, regimen, twice, risk, advantage, reactions, severe
Sections
Article Source

PURLs Copyright

Inside the Article

Article PDF Media

Cold Urticaria: A Case Report and Review of the Literature

Article Type
Changed
Display Headline
Cold Urticaria: A Case Report and Review of the Literature

Case Report

An otherwise healthy 9-year-old Filipino girl presented with a complaint of urticaria precipitated by cold exposure over the preceding 5 weeks. She had no recent illnesses and normal results of a school physical examination performed 2 weeks prior to symptom onset. The patient's medical history was significant only for cat allergy; however, she noted that on multiple occasions, erythema and pruritus appeared on her arms and face after walking through the freezer aisle of a grocery store. Urticaria subsequently developed on regions where she scratched and spontaneously resolved 2 to 3 hours later. On one occasion, urticaria appeared diffusely on the patient while she showered after swimming; it resolved within a few hours after she was given diphenhydramine by her mother. Three days prior to presentation, the patient experienced upper lip angioedema with erythema, globus sensation, and difficulty swallowing after drinking a strawberry slushy. She denied having respiratory complaints at that time, and her symptoms again resolved spontaneously. A day later, the patient tolerated ice cream with no complaints. Her family history was significant for a maternal history of seasonal allergies.

On physical examination, the patient appeared to be well. She had 2 to 3 discrete urticarial lesions on the distal posterior aspect of each calf that, according to her mother, recently began appearing on "cold and rainy" days. The mother attributed them to her daughter's lower legs being exposed because of the length of her pants. Results of the remainder of the examination were unremarkable, and dermatographism was absent.

Laboratory evaluation consisted of a strawberry radioallergosorbent test and cryoglobulins test, both of which had negative results. An ice cube wrapped in plastic was applied to the volar surface of the patient's right forearm for 5 minutes. A 9X6-cm wheal was noted 3 minutes after ice removal (Figure).

PLEASE REFER TO THE PDF TO VIEW THE FIGURE

A diagnosis of cold urticaria with associated angioedema was made. The patient's mother opted for her daughter to use only diphenhydramine as needed; additionally, an epinephrine autoinjector was dispensed. By 3 months after symptom onset, the patient's only complaint was pruritus of her hands if they became too cold. No urticaria was noted. At 6-month follow-up, the patient denied having had symptoms for the preceding 2 months, and the results of an ice cube test were negative. 


Comment

Cold urticaria is a form of physical urticaria that is notable for the development of urticaria and/or angioedema after cold exposure.1 Cold urticaria syndromes were first described in the 19th century2 and are uncommon. However, it has been observed that approximately one third of adult3 and pediatric4 patients with cold urticaria have systemic reactions that are mostly hypotensive episodes associated with aquatic activities. Thus, identification of these patients should be a priority.

The prevalence of cold urticaria is not well defined. Cold urticaria is most commonly noted in young adults, with only 11% of cases noted in children under 10 years of age.3 Most forms of cold urticaria are idiopathic (Table); however, some forms can be secondary to underlying conditions such as malignancies, vasculitides, and infectious diseases.8 Cryoglobulinemia (primary and secondary to malignancy) often is cited as a cause of secondary cold urticaria.3,8-11 Mounting evidence indicates that a possible autoimmune mechanism underlies the idiopathic form of this disorder in many patients.12

PLEASE REFER TO THE PDF TO VIEW THE TABLE

Although most forms of cold urticaria are considered to be acquired, familial forms have been described,7,13 some of which have been classified within the hereditary periodic fever syndromes.12 Diagnosis of cold urticaria primarily is made by evaluating the patient's clinical history; the diagnosis may be confirmed by applying a cold stimulus, most commonly an ice cube wrapped in plastic and applied to the volar aspect of the patient's forearm. A positive reaction is noted by the formation of a wheal during rewarming of the skin. The length of time that a cold stimulus is applied is not standardized; commonly, 3-, 5-, and 10-minute applications are used. Visitsuntorn et al14 observed the effectiveness of 3- or 5-minute applications in children who had not taken antihistamines for at least 5 days prior. The authors also noted that false-positive results (defined as reddening of the skin and minimal edema) were possible with 10- and 20-minute applications in patients with chronic urticaria not induced by cold. Other studies have observed that the length of time necessary for a cold stimulus to induce wheal formation inversely may be related to the patient's risk of having a systemic reaction.1,8,12 Specifically, patients who demonstrated wheal formation after the application of a cold stimulus for 3 minutes or less were noted to experience cold-induced hypotension more frequently. Regardless, it should be recognized that all patients with cold urticaria are at risk for hypotensive reactions.

 

 

Approximately 20% of patients with cold urticaria lack an immediate response to cold stimulus with an ice cube; these patients have so-called atypical acquired cold urticaria syndromes1,12 (eg, cold-dependant dermatographism, delayed cold urticaria, systemic cold urticaria). Other forms of cold stimulus testing that can be considered include partially immersing a limb of the patient's in cold water3 or placing the patient in a cold room15; however, these forms of cold stimulus may put the patient at increased risk for a systemic reaction. Finally, scratching the skin prior to cooling or during cooling also may be of diagnostic value in cases of cold-dependant dermatographism.9,15

Additional testing should be guided by a patient's history. To determine if a secondary cause is responsible for the clinical presentation of cold urticaria, laboratory studies could include complete blood count, erythrocyte sedimentation rate, antinuclear antibodies titer, infectious mononucleosis serology, syphilis serology, rheumatoid factor, total complement, cold agglutinins, cold hemolysin, cryofibrinogen, and cryoglobulin.12 Of note, approximately 4% of patients with cold urticaria have been observed to have cryoglobulinemia. Thus, testing for cryoglobulinemia is the most likely laboratory study to yield positive results.1,16 Beyond evaluation for cryoprecipitates, however, an extensive search for etiology is not indicated unless additional clinical findings warrant investigation.16

Treatment of patients with cold urticaria can be difficult. Patients and their families should be counseled on the risks of aquatic activities and should be instructed on the proper use of an epinephrine autoinjector. In severe cases, patients may elect to move to warmer climates. Antihistamines sometimes provide benefit, especially at high doses and/or with the more potent formulations, such as doxepin. Cyproheptadine has been shown to be more effective than chlorpheniramine.17 Second-generation antihistamines also may be considered to minimize sedation. Cetirizine, loratadine, and desloratadine have been shown to be effective and well-tolerated options for treatment.18,19 Additionally, leukotriene receptor antagonists may have a role in treatment.5 Bonadonna et al6 demonstrated that cetirizine and zafirlukast in combination are more effective than either drug alone. Adjusting the level of medication so that the patient requires more than 3 minutes of cold stimulus testing before having a wheal response is a recommended goal of therapy that is aimed at minimizing the patient's risk of having a hypotensive reaction.12

Cold urticaria is an uncommon disorder that can put patients at significant risk. Taking a thorough history and confirming the condition through the use of cold stimulation tests can lead to a diagnosis in most cases. Although most forms of cold urticaria are idiopathic and acquired, familial and secondary forms also must be kept in mind when considering this diagnosis. In addition to antihistamine therapy, an epinephrine autoinjector and preventive measures play an important role in treating patients with cold urticaria. 

References

  1. Wanderer AA, Grandel KE, Wasserman SI, et al. Clinical characteristics of cold-induced systemic reactions in acquired cold urticaria syndromes: recommendations for prevention of this complication and a proposal for a diagnostic classification of cold urticaria. J Allergy Clin Immunol. 1986;78:417-423.
  2. Bourdon H. Note Sur L'uticaire intermittente. Bull Mem Soc Med Hop Paris. 1866;3:259-262.
  3. Neittaanmaki H. Cold urticaria. clinical findings in 220 patients. J Am Acad Dermatol. 1985;13:636-644.
  4. Alangari AA, Twarog FJ, Shih MC, et al. Clinical features and anaphylaxis in children with cold urticaria. Pediatrics. 2004;113:e313-e317.
  5. Hani N, Hartmann K, Casper C, et al. Improvement of cold urticaria by treatment with the leukotriene receptor antagonist montelukast [letter]. Acta Derm Venereol. 2000;80:229.
  6. Bonadonna P, Lombardi C, Gianenrico S, et al. Treatment of acquired cold urticaria with cetirizine and zafirlukast in combination. J Am Acad Dermatol. 2003;49:714-716.
  7. Soter NA, Joshi NP, Twarog FJ, et al. Delayed cold-induced urticaria: a dominantly inherited disorder. J Allergy Clin Immunol. 1977;59:294-297.
  8. Wanderer A. Cold urticaria syndromes: historical background, diagnostic classification, clinical and laboratory characteristics, pathogenesis, and management. J Allergy Clin Immunol. 1990;85:965-981.
  9. Costanzi JJ, Coltman CA. Kappa chain cold precipitable immunoglobulin G (IgG) associated with cold urticaria, I: clinical observations. Clin Exp Immunol. 1967;2:167-178.
  10. Rawnsley HM, Shelley WB. Cold urticaria with cryoglobulinemia in a patient with chronic lymphocytic leukemia. Arch Dermatol. 1968;98:12-17.
  11. Hauptmann G, Lang JM, North ML, et al. Lymphosarcoma, cold urticaria, IgG1 monoclonal cryoglobulin, and compliment abnormalities. Scand J Haematol. 1975;15:22-26.
  12. Wanderer AA, Hoffman HM. The spectrum of acquired and familial cold-induced urticaria/urticaria-like syndromes. Immunol Allergy Clin North Am. 2004;24:259-286.
  13. Hoffman HM, Wright FA, Broide DH, et al. Identification of a locus on chromosome 1q44 for familial cold urticaria. Am J Hum Genet. 2000;66:1693-1698.
  14. Visitsuntorn N, Tuchinda M, Arunyanark N, et al. Ice cube test in children with cold urticaria. Asian Pac J Allergy Immunol. 1992;10:111-115.
  15. Kaplan AP. Unusual cold-induced disorders: cold-dependant dermatographism and systemic cold urticaria. J Allergy Clin Immunol. 1984;73:453-456.
  16. Koeppel MC, Bertrand S, Abitan R, et al. Urticaria caused by cold. 104 cases [in French]. Ann Dermatol Venereol. 1996;123:627-632.
  17. Wanderer AA, St Pierre JP, Ellis EF. Primary acquired cold urticaria. double-blind comparative study of treatment with cyproheptadine, chlorpheniramine, and placebo. Arch Dermatol. 1977;113:1375-1377.
  18. Villas Martinez F, Contreras FJ, Lopez Cazana JM, et al. A comparison of new nonsedating and classical antihistamines in the treatment of primary acquired cold urticaria (ACU). J Investig Allergol Clin Immunol. 1992;2:258-262.
  19. Juhlin L. Inhibition of cold urticaria by desloratidine. J Dermatolog Treat. 2004;15:51-59.
Article PDF
Author and Disclosure Information

Mark S. La Shell, MD; Michael S. Tankersley, MD; Machiko Kobayashi, RN

Dr. La Shell is a staff pediatrician and Ms. Kobayashi is a pediatric nurse, Department of Pediatrics, 374th Medical Group, Yokota Air Force Base, Tokyo, Japan. Dr. Tankersley is Chief, Department of Allergy, Asthma and Immunology, Third Medical Group, Elmendorf Air Force Base, Anchorage, Alaska.

Drs. La Shell and Tankersley and Ms. Kobayashi report no conflict of interest.

The views expressed in this article are those of the authors and do not reflect the official policy of the US Department of Defense or other Departments of the US Government.

Issue
Cutis - 76(4)
Publications
Topics
Page Number
257-260
Author and Disclosure Information

Mark S. La Shell, MD; Michael S. Tankersley, MD; Machiko Kobayashi, RN

Dr. La Shell is a staff pediatrician and Ms. Kobayashi is a pediatric nurse, Department of Pediatrics, 374th Medical Group, Yokota Air Force Base, Tokyo, Japan. Dr. Tankersley is Chief, Department of Allergy, Asthma and Immunology, Third Medical Group, Elmendorf Air Force Base, Anchorage, Alaska.

Drs. La Shell and Tankersley and Ms. Kobayashi report no conflict of interest.

The views expressed in this article are those of the authors and do not reflect the official policy of the US Department of Defense or other Departments of the US Government.

Author and Disclosure Information

Mark S. La Shell, MD; Michael S. Tankersley, MD; Machiko Kobayashi, RN

Dr. La Shell is a staff pediatrician and Ms. Kobayashi is a pediatric nurse, Department of Pediatrics, 374th Medical Group, Yokota Air Force Base, Tokyo, Japan. Dr. Tankersley is Chief, Department of Allergy, Asthma and Immunology, Third Medical Group, Elmendorf Air Force Base, Anchorage, Alaska.

Drs. La Shell and Tankersley and Ms. Kobayashi report no conflict of interest.

The views expressed in this article are those of the authors and do not reflect the official policy of the US Department of Defense or other Departments of the US Government.

Article PDF
Article PDF

Case Report

An otherwise healthy 9-year-old Filipino girl presented with a complaint of urticaria precipitated by cold exposure over the preceding 5 weeks. She had no recent illnesses and normal results of a school physical examination performed 2 weeks prior to symptom onset. The patient's medical history was significant only for cat allergy; however, she noted that on multiple occasions, erythema and pruritus appeared on her arms and face after walking through the freezer aisle of a grocery store. Urticaria subsequently developed on regions where she scratched and spontaneously resolved 2 to 3 hours later. On one occasion, urticaria appeared diffusely on the patient while she showered after swimming; it resolved within a few hours after she was given diphenhydramine by her mother. Three days prior to presentation, the patient experienced upper lip angioedema with erythema, globus sensation, and difficulty swallowing after drinking a strawberry slushy. She denied having respiratory complaints at that time, and her symptoms again resolved spontaneously. A day later, the patient tolerated ice cream with no complaints. Her family history was significant for a maternal history of seasonal allergies.

On physical examination, the patient appeared to be well. She had 2 to 3 discrete urticarial lesions on the distal posterior aspect of each calf that, according to her mother, recently began appearing on "cold and rainy" days. The mother attributed them to her daughter's lower legs being exposed because of the length of her pants. Results of the remainder of the examination were unremarkable, and dermatographism was absent.

Laboratory evaluation consisted of a strawberry radioallergosorbent test and cryoglobulins test, both of which had negative results. An ice cube wrapped in plastic was applied to the volar surface of the patient's right forearm for 5 minutes. A 9X6-cm wheal was noted 3 minutes after ice removal (Figure).

PLEASE REFER TO THE PDF TO VIEW THE FIGURE

A diagnosis of cold urticaria with associated angioedema was made. The patient's mother opted for her daughter to use only diphenhydramine as needed; additionally, an epinephrine autoinjector was dispensed. By 3 months after symptom onset, the patient's only complaint was pruritus of her hands if they became too cold. No urticaria was noted. At 6-month follow-up, the patient denied having had symptoms for the preceding 2 months, and the results of an ice cube test were negative. 


Comment

Cold urticaria is a form of physical urticaria that is notable for the development of urticaria and/or angioedema after cold exposure.1 Cold urticaria syndromes were first described in the 19th century2 and are uncommon. However, it has been observed that approximately one third of adult3 and pediatric4 patients with cold urticaria have systemic reactions that are mostly hypotensive episodes associated with aquatic activities. Thus, identification of these patients should be a priority.

The prevalence of cold urticaria is not well defined. Cold urticaria is most commonly noted in young adults, with only 11% of cases noted in children under 10 years of age.3 Most forms of cold urticaria are idiopathic (Table); however, some forms can be secondary to underlying conditions such as malignancies, vasculitides, and infectious diseases.8 Cryoglobulinemia (primary and secondary to malignancy) often is cited as a cause of secondary cold urticaria.3,8-11 Mounting evidence indicates that a possible autoimmune mechanism underlies the idiopathic form of this disorder in many patients.12

PLEASE REFER TO THE PDF TO VIEW THE TABLE

Although most forms of cold urticaria are considered to be acquired, familial forms have been described,7,13 some of which have been classified within the hereditary periodic fever syndromes.12 Diagnosis of cold urticaria primarily is made by evaluating the patient's clinical history; the diagnosis may be confirmed by applying a cold stimulus, most commonly an ice cube wrapped in plastic and applied to the volar aspect of the patient's forearm. A positive reaction is noted by the formation of a wheal during rewarming of the skin. The length of time that a cold stimulus is applied is not standardized; commonly, 3-, 5-, and 10-minute applications are used. Visitsuntorn et al14 observed the effectiveness of 3- or 5-minute applications in children who had not taken antihistamines for at least 5 days prior. The authors also noted that false-positive results (defined as reddening of the skin and minimal edema) were possible with 10- and 20-minute applications in patients with chronic urticaria not induced by cold. Other studies have observed that the length of time necessary for a cold stimulus to induce wheal formation inversely may be related to the patient's risk of having a systemic reaction.1,8,12 Specifically, patients who demonstrated wheal formation after the application of a cold stimulus for 3 minutes or less were noted to experience cold-induced hypotension more frequently. Regardless, it should be recognized that all patients with cold urticaria are at risk for hypotensive reactions.

 

 

Approximately 20% of patients with cold urticaria lack an immediate response to cold stimulus with an ice cube; these patients have so-called atypical acquired cold urticaria syndromes1,12 (eg, cold-dependant dermatographism, delayed cold urticaria, systemic cold urticaria). Other forms of cold stimulus testing that can be considered include partially immersing a limb of the patient's in cold water3 or placing the patient in a cold room15; however, these forms of cold stimulus may put the patient at increased risk for a systemic reaction. Finally, scratching the skin prior to cooling or during cooling also may be of diagnostic value in cases of cold-dependant dermatographism.9,15

Additional testing should be guided by a patient's history. To determine if a secondary cause is responsible for the clinical presentation of cold urticaria, laboratory studies could include complete blood count, erythrocyte sedimentation rate, antinuclear antibodies titer, infectious mononucleosis serology, syphilis serology, rheumatoid factor, total complement, cold agglutinins, cold hemolysin, cryofibrinogen, and cryoglobulin.12 Of note, approximately 4% of patients with cold urticaria have been observed to have cryoglobulinemia. Thus, testing for cryoglobulinemia is the most likely laboratory study to yield positive results.1,16 Beyond evaluation for cryoprecipitates, however, an extensive search for etiology is not indicated unless additional clinical findings warrant investigation.16

Treatment of patients with cold urticaria can be difficult. Patients and their families should be counseled on the risks of aquatic activities and should be instructed on the proper use of an epinephrine autoinjector. In severe cases, patients may elect to move to warmer climates. Antihistamines sometimes provide benefit, especially at high doses and/or with the more potent formulations, such as doxepin. Cyproheptadine has been shown to be more effective than chlorpheniramine.17 Second-generation antihistamines also may be considered to minimize sedation. Cetirizine, loratadine, and desloratadine have been shown to be effective and well-tolerated options for treatment.18,19 Additionally, leukotriene receptor antagonists may have a role in treatment.5 Bonadonna et al6 demonstrated that cetirizine and zafirlukast in combination are more effective than either drug alone. Adjusting the level of medication so that the patient requires more than 3 minutes of cold stimulus testing before having a wheal response is a recommended goal of therapy that is aimed at minimizing the patient's risk of having a hypotensive reaction.12

Cold urticaria is an uncommon disorder that can put patients at significant risk. Taking a thorough history and confirming the condition through the use of cold stimulation tests can lead to a diagnosis in most cases. Although most forms of cold urticaria are idiopathic and acquired, familial and secondary forms also must be kept in mind when considering this diagnosis. In addition to antihistamine therapy, an epinephrine autoinjector and preventive measures play an important role in treating patients with cold urticaria. 

Case Report

An otherwise healthy 9-year-old Filipino girl presented with a complaint of urticaria precipitated by cold exposure over the preceding 5 weeks. She had no recent illnesses and normal results of a school physical examination performed 2 weeks prior to symptom onset. The patient's medical history was significant only for cat allergy; however, she noted that on multiple occasions, erythema and pruritus appeared on her arms and face after walking through the freezer aisle of a grocery store. Urticaria subsequently developed on regions where she scratched and spontaneously resolved 2 to 3 hours later. On one occasion, urticaria appeared diffusely on the patient while she showered after swimming; it resolved within a few hours after she was given diphenhydramine by her mother. Three days prior to presentation, the patient experienced upper lip angioedema with erythema, globus sensation, and difficulty swallowing after drinking a strawberry slushy. She denied having respiratory complaints at that time, and her symptoms again resolved spontaneously. A day later, the patient tolerated ice cream with no complaints. Her family history was significant for a maternal history of seasonal allergies.

On physical examination, the patient appeared to be well. She had 2 to 3 discrete urticarial lesions on the distal posterior aspect of each calf that, according to her mother, recently began appearing on "cold and rainy" days. The mother attributed them to her daughter's lower legs being exposed because of the length of her pants. Results of the remainder of the examination were unremarkable, and dermatographism was absent.

Laboratory evaluation consisted of a strawberry radioallergosorbent test and cryoglobulins test, both of which had negative results. An ice cube wrapped in plastic was applied to the volar surface of the patient's right forearm for 5 minutes. A 9X6-cm wheal was noted 3 minutes after ice removal (Figure).

PLEASE REFER TO THE PDF TO VIEW THE FIGURE

A diagnosis of cold urticaria with associated angioedema was made. The patient's mother opted for her daughter to use only diphenhydramine as needed; additionally, an epinephrine autoinjector was dispensed. By 3 months after symptom onset, the patient's only complaint was pruritus of her hands if they became too cold. No urticaria was noted. At 6-month follow-up, the patient denied having had symptoms for the preceding 2 months, and the results of an ice cube test were negative. 


Comment

Cold urticaria is a form of physical urticaria that is notable for the development of urticaria and/or angioedema after cold exposure.1 Cold urticaria syndromes were first described in the 19th century2 and are uncommon. However, it has been observed that approximately one third of adult3 and pediatric4 patients with cold urticaria have systemic reactions that are mostly hypotensive episodes associated with aquatic activities. Thus, identification of these patients should be a priority.

The prevalence of cold urticaria is not well defined. Cold urticaria is most commonly noted in young adults, with only 11% of cases noted in children under 10 years of age.3 Most forms of cold urticaria are idiopathic (Table); however, some forms can be secondary to underlying conditions such as malignancies, vasculitides, and infectious diseases.8 Cryoglobulinemia (primary and secondary to malignancy) often is cited as a cause of secondary cold urticaria.3,8-11 Mounting evidence indicates that a possible autoimmune mechanism underlies the idiopathic form of this disorder in many patients.12

PLEASE REFER TO THE PDF TO VIEW THE TABLE

Although most forms of cold urticaria are considered to be acquired, familial forms have been described,7,13 some of which have been classified within the hereditary periodic fever syndromes.12 Diagnosis of cold urticaria primarily is made by evaluating the patient's clinical history; the diagnosis may be confirmed by applying a cold stimulus, most commonly an ice cube wrapped in plastic and applied to the volar aspect of the patient's forearm. A positive reaction is noted by the formation of a wheal during rewarming of the skin. The length of time that a cold stimulus is applied is not standardized; commonly, 3-, 5-, and 10-minute applications are used. Visitsuntorn et al14 observed the effectiveness of 3- or 5-minute applications in children who had not taken antihistamines for at least 5 days prior. The authors also noted that false-positive results (defined as reddening of the skin and minimal edema) were possible with 10- and 20-minute applications in patients with chronic urticaria not induced by cold. Other studies have observed that the length of time necessary for a cold stimulus to induce wheal formation inversely may be related to the patient's risk of having a systemic reaction.1,8,12 Specifically, patients who demonstrated wheal formation after the application of a cold stimulus for 3 minutes or less were noted to experience cold-induced hypotension more frequently. Regardless, it should be recognized that all patients with cold urticaria are at risk for hypotensive reactions.

 

 

Approximately 20% of patients with cold urticaria lack an immediate response to cold stimulus with an ice cube; these patients have so-called atypical acquired cold urticaria syndromes1,12 (eg, cold-dependant dermatographism, delayed cold urticaria, systemic cold urticaria). Other forms of cold stimulus testing that can be considered include partially immersing a limb of the patient's in cold water3 or placing the patient in a cold room15; however, these forms of cold stimulus may put the patient at increased risk for a systemic reaction. Finally, scratching the skin prior to cooling or during cooling also may be of diagnostic value in cases of cold-dependant dermatographism.9,15

Additional testing should be guided by a patient's history. To determine if a secondary cause is responsible for the clinical presentation of cold urticaria, laboratory studies could include complete blood count, erythrocyte sedimentation rate, antinuclear antibodies titer, infectious mononucleosis serology, syphilis serology, rheumatoid factor, total complement, cold agglutinins, cold hemolysin, cryofibrinogen, and cryoglobulin.12 Of note, approximately 4% of patients with cold urticaria have been observed to have cryoglobulinemia. Thus, testing for cryoglobulinemia is the most likely laboratory study to yield positive results.1,16 Beyond evaluation for cryoprecipitates, however, an extensive search for etiology is not indicated unless additional clinical findings warrant investigation.16

Treatment of patients with cold urticaria can be difficult. Patients and their families should be counseled on the risks of aquatic activities and should be instructed on the proper use of an epinephrine autoinjector. In severe cases, patients may elect to move to warmer climates. Antihistamines sometimes provide benefit, especially at high doses and/or with the more potent formulations, such as doxepin. Cyproheptadine has been shown to be more effective than chlorpheniramine.17 Second-generation antihistamines also may be considered to minimize sedation. Cetirizine, loratadine, and desloratadine have been shown to be effective and well-tolerated options for treatment.18,19 Additionally, leukotriene receptor antagonists may have a role in treatment.5 Bonadonna et al6 demonstrated that cetirizine and zafirlukast in combination are more effective than either drug alone. Adjusting the level of medication so that the patient requires more than 3 minutes of cold stimulus testing before having a wheal response is a recommended goal of therapy that is aimed at minimizing the patient's risk of having a hypotensive reaction.12

Cold urticaria is an uncommon disorder that can put patients at significant risk. Taking a thorough history and confirming the condition through the use of cold stimulation tests can lead to a diagnosis in most cases. Although most forms of cold urticaria are idiopathic and acquired, familial and secondary forms also must be kept in mind when considering this diagnosis. In addition to antihistamine therapy, an epinephrine autoinjector and preventive measures play an important role in treating patients with cold urticaria. 

References

  1. Wanderer AA, Grandel KE, Wasserman SI, et al. Clinical characteristics of cold-induced systemic reactions in acquired cold urticaria syndromes: recommendations for prevention of this complication and a proposal for a diagnostic classification of cold urticaria. J Allergy Clin Immunol. 1986;78:417-423.
  2. Bourdon H. Note Sur L'uticaire intermittente. Bull Mem Soc Med Hop Paris. 1866;3:259-262.
  3. Neittaanmaki H. Cold urticaria. clinical findings in 220 patients. J Am Acad Dermatol. 1985;13:636-644.
  4. Alangari AA, Twarog FJ, Shih MC, et al. Clinical features and anaphylaxis in children with cold urticaria. Pediatrics. 2004;113:e313-e317.
  5. Hani N, Hartmann K, Casper C, et al. Improvement of cold urticaria by treatment with the leukotriene receptor antagonist montelukast [letter]. Acta Derm Venereol. 2000;80:229.
  6. Bonadonna P, Lombardi C, Gianenrico S, et al. Treatment of acquired cold urticaria with cetirizine and zafirlukast in combination. J Am Acad Dermatol. 2003;49:714-716.
  7. Soter NA, Joshi NP, Twarog FJ, et al. Delayed cold-induced urticaria: a dominantly inherited disorder. J Allergy Clin Immunol. 1977;59:294-297.
  8. Wanderer A. Cold urticaria syndromes: historical background, diagnostic classification, clinical and laboratory characteristics, pathogenesis, and management. J Allergy Clin Immunol. 1990;85:965-981.
  9. Costanzi JJ, Coltman CA. Kappa chain cold precipitable immunoglobulin G (IgG) associated with cold urticaria, I: clinical observations. Clin Exp Immunol. 1967;2:167-178.
  10. Rawnsley HM, Shelley WB. Cold urticaria with cryoglobulinemia in a patient with chronic lymphocytic leukemia. Arch Dermatol. 1968;98:12-17.
  11. Hauptmann G, Lang JM, North ML, et al. Lymphosarcoma, cold urticaria, IgG1 monoclonal cryoglobulin, and compliment abnormalities. Scand J Haematol. 1975;15:22-26.
  12. Wanderer AA, Hoffman HM. The spectrum of acquired and familial cold-induced urticaria/urticaria-like syndromes. Immunol Allergy Clin North Am. 2004;24:259-286.
  13. Hoffman HM, Wright FA, Broide DH, et al. Identification of a locus on chromosome 1q44 for familial cold urticaria. Am J Hum Genet. 2000;66:1693-1698.
  14. Visitsuntorn N, Tuchinda M, Arunyanark N, et al. Ice cube test in children with cold urticaria. Asian Pac J Allergy Immunol. 1992;10:111-115.
  15. Kaplan AP. Unusual cold-induced disorders: cold-dependant dermatographism and systemic cold urticaria. J Allergy Clin Immunol. 1984;73:453-456.
  16. Koeppel MC, Bertrand S, Abitan R, et al. Urticaria caused by cold. 104 cases [in French]. Ann Dermatol Venereol. 1996;123:627-632.
  17. Wanderer AA, St Pierre JP, Ellis EF. Primary acquired cold urticaria. double-blind comparative study of treatment with cyproheptadine, chlorpheniramine, and placebo. Arch Dermatol. 1977;113:1375-1377.
  18. Villas Martinez F, Contreras FJ, Lopez Cazana JM, et al. A comparison of new nonsedating and classical antihistamines in the treatment of primary acquired cold urticaria (ACU). J Investig Allergol Clin Immunol. 1992;2:258-262.
  19. Juhlin L. Inhibition of cold urticaria by desloratidine. J Dermatolog Treat. 2004;15:51-59.
References

  1. Wanderer AA, Grandel KE, Wasserman SI, et al. Clinical characteristics of cold-induced systemic reactions in acquired cold urticaria syndromes: recommendations for prevention of this complication and a proposal for a diagnostic classification of cold urticaria. J Allergy Clin Immunol. 1986;78:417-423.
  2. Bourdon H. Note Sur L'uticaire intermittente. Bull Mem Soc Med Hop Paris. 1866;3:259-262.
  3. Neittaanmaki H. Cold urticaria. clinical findings in 220 patients. J Am Acad Dermatol. 1985;13:636-644.
  4. Alangari AA, Twarog FJ, Shih MC, et al. Clinical features and anaphylaxis in children with cold urticaria. Pediatrics. 2004;113:e313-e317.
  5. Hani N, Hartmann K, Casper C, et al. Improvement of cold urticaria by treatment with the leukotriene receptor antagonist montelukast [letter]. Acta Derm Venereol. 2000;80:229.
  6. Bonadonna P, Lombardi C, Gianenrico S, et al. Treatment of acquired cold urticaria with cetirizine and zafirlukast in combination. J Am Acad Dermatol. 2003;49:714-716.
  7. Soter NA, Joshi NP, Twarog FJ, et al. Delayed cold-induced urticaria: a dominantly inherited disorder. J Allergy Clin Immunol. 1977;59:294-297.
  8. Wanderer A. Cold urticaria syndromes: historical background, diagnostic classification, clinical and laboratory characteristics, pathogenesis, and management. J Allergy Clin Immunol. 1990;85:965-981.
  9. Costanzi JJ, Coltman CA. Kappa chain cold precipitable immunoglobulin G (IgG) associated with cold urticaria, I: clinical observations. Clin Exp Immunol. 1967;2:167-178.
  10. Rawnsley HM, Shelley WB. Cold urticaria with cryoglobulinemia in a patient with chronic lymphocytic leukemia. Arch Dermatol. 1968;98:12-17.
  11. Hauptmann G, Lang JM, North ML, et al. Lymphosarcoma, cold urticaria, IgG1 monoclonal cryoglobulin, and compliment abnormalities. Scand J Haematol. 1975;15:22-26.
  12. Wanderer AA, Hoffman HM. The spectrum of acquired and familial cold-induced urticaria/urticaria-like syndromes. Immunol Allergy Clin North Am. 2004;24:259-286.
  13. Hoffman HM, Wright FA, Broide DH, et al. Identification of a locus on chromosome 1q44 for familial cold urticaria. Am J Hum Genet. 2000;66:1693-1698.
  14. Visitsuntorn N, Tuchinda M, Arunyanark N, et al. Ice cube test in children with cold urticaria. Asian Pac J Allergy Immunol. 1992;10:111-115.
  15. Kaplan AP. Unusual cold-induced disorders: cold-dependant dermatographism and systemic cold urticaria. J Allergy Clin Immunol. 1984;73:453-456.
  16. Koeppel MC, Bertrand S, Abitan R, et al. Urticaria caused by cold. 104 cases [in French]. Ann Dermatol Venereol. 1996;123:627-632.
  17. Wanderer AA, St Pierre JP, Ellis EF. Primary acquired cold urticaria. double-blind comparative study of treatment with cyproheptadine, chlorpheniramine, and placebo. Arch Dermatol. 1977;113:1375-1377.
  18. Villas Martinez F, Contreras FJ, Lopez Cazana JM, et al. A comparison of new nonsedating and classical antihistamines in the treatment of primary acquired cold urticaria (ACU). J Investig Allergol Clin Immunol. 1992;2:258-262.
  19. Juhlin L. Inhibition of cold urticaria by desloratidine. J Dermatolog Treat. 2004;15:51-59.
Issue
Cutis - 76(4)
Issue
Cutis - 76(4)
Page Number
257-260
Page Number
257-260
Publications
Publications
Topics
Article Type
Display Headline
Cold Urticaria: A Case Report and Review of the Literature
Display Headline
Cold Urticaria: A Case Report and Review of the Literature
Article Source

PURLs Copyright

Inside the Article

Article PDF Media

Enhancing the Care and Treatment of Skin of Color, Part 1: The Broad Scope of Pigmentary Disorders

Article Type
Changed
Display Headline
Enhancing the Care and Treatment of Skin of Color, Part 1: The Broad Scope of Pigmentary Disorders

Article PDF
Author and Disclosure Information

Taylor SC

Issue
Cutis - 76(4)
Publications
Page Number
249-255
Sections
Author and Disclosure Information

Taylor SC

Author and Disclosure Information

Taylor SC

Article PDF
Article PDF

Issue
Cutis - 76(4)
Issue
Cutis - 76(4)
Page Number
249-255
Page Number
249-255
Publications
Publications
Article Type
Display Headline
Enhancing the Care and Treatment of Skin of Color, Part 1: The Broad Scope of Pigmentary Disorders
Display Headline
Enhancing the Care and Treatment of Skin of Color, Part 1: The Broad Scope of Pigmentary Disorders
Sections
Article Source

PURLs Copyright

Inside the Article

Article PDF Media

The Vitamin D and Sunlight Controversy—We Will Wait and See [editorial]

Article Type
Changed
Display Headline
The Vitamin D and Sunlight Controversy—We Will Wait and See [editorial]

Article PDF
Author and Disclosure Information

DeLeo VA

Issue
Cutis - 76(4)
Publications
Topics
Page Number
229
Sections
Author and Disclosure Information

DeLeo VA

Author and Disclosure Information

DeLeo VA

Article PDF
Article PDF

Issue
Cutis - 76(4)
Issue
Cutis - 76(4)
Page Number
229
Page Number
229
Publications
Publications
Topics
Article Type
Display Headline
The Vitamin D and Sunlight Controversy—We Will Wait and See [editorial]
Display Headline
The Vitamin D and Sunlight Controversy—We Will Wait and See [editorial]
Sections
Article Source

PURLs Copyright

Inside the Article

Article PDF Media